Substrate metabolism, hormone and cytokine levels and adipose tissue signalling in individuals with type 1 diabetes after insulin withdrawal and subsequent insulin therapy to model the initiating steps of ketoacidosis
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Aims/hypothesis Lack of insulin and infection/inflammation are the two most common causes of diabetic ketoacidosis (DKA). We used insulin withdrawal followed by insulin administration as a clinical model to define effects on substrate metabolism and to test whether increased levels of counter-regulatory hormones and cytokines and altered adipose tissue signalling participate in the early phases of DKA.Methods Nine individuals with type 1 diabetes, without complications, were randomly studied twice, in a crossover design, for 5 h followed by 2.5 h high-dose insulin clamp: (1) insulin-controlled euglycaemia (control) and (2) after 14 h of insulin withdrawal in a university hospital setting.Results Insulin withdrawal increased levels of glucose (6.1 ± 0.5 vs 18.6 ± 0.5 mmol/l), NEFA, 3-OHB (127 ± 18 vs 1837 ± 298 μmol/l), glucagon, cortisol and growth hormone and decreased HCO 3- and pH, without affecting catecholamine or cytokine levels. Whole-body energy expenditure, endogenous glucose production (1.55 ± 0.13 vs 2.70 ± 0.31 mg kg-1 min-1), glucose turnover, non-oxidative glucose disposal, lipid oxidation, palmitate flux (73 [range 39-104] vs 239 [151-474] μmol/min), protein oxidation and phenylalanine flux all increased, whereas glucose oxidation decreased. In adipose tissue, Ser473 phosphorylation of Akt and mRNA levels of G0S2 decreased, whereas CGI-58 (also known as ABHD5) mRNA increased. Protein levels of adipose triglyceride lipase (ATGL) and hormone-sensitive lipase phosphorylations were unaltered. Insulin therapy decreased plasma glucose concentrations dramatically after insulin withdrawal, without any detectable effect on net forearm glucose uptake.Conclusions/interpretation Release of counter-regulatory hormones and overall increased catabolism, including lipolysis, are prominent features of preacidotic ketosis induced by insulin withdrawal, and dampening of Akt insulin signalling and transcriptional modulation of ATGL activity are involved. The lack of any increase in net forearm glucose uptake during insulin therapy after insulin withdrawal indicates muscle insulin resistance.Trial registration ClinicalTrials.gov NCT02077348 FUNDING: This study was supported by Aarhus University and the KETO Study Group/Danish Agency for Science Technology and Innovation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“T1D is defined as b-cell destruction and absolute insulin deficiency.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1112]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemic crises in adult patients with diabetes
Kitabchi, A. E., Umpierrez, G. E., Miles, J. M., & Fisher, J. N. (2009) · Diabetes Care · doi:10.2337/dc09-9032 · Cited by 2,062
INFLUENCES OF GLUCOSE LOADING AND OF INJECTED INSULIN ON HEPATIC GLUCOSE OUTPUT*
Steele, R. (1959) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1959.tb44923.x · Cited by 1,670
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
The measurement of volume changes in human limbs
Whitney, R. J. (1953) · The Journal of Physiology · doi:10.1113/jphysiol.1953.sp004926 · Cited by 1,489
Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects
Møller, N., & Jørgensen, J. O. L. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0027 · Cited by 1,039
Self-citation(2018) · doi:10.1001/jama · Cited by 932
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010
Livingstone, S. J., Levin, D., Looker, H. C., Lindsay, R. S., Wild, S. H., Joss, N., Leese, G., Leslie, P., McCrimmon, R. J., Metcalfe, W., et al. (2015) · JAMA · doi:10.1001/jama.2014.16425 · Cited by 621
Liu, C., Wu, J., Zhu, J., Kuei, C., Yu, J., Shelton, J., Sutton, S. W., Li, X., Yun, S. J., Mirzadegan, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806409200 · Cited by 606
Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Stentz, F. B., Umpierrez, G. E., Cuervo, R., & Kitabchi, A. E. (2004) · Diabetes · doi:10.2337/diabetes.53.8.2079 · Cited by 497
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Nielsen, T. S., Jessen, N., Jørgensen, J. O. L., Møller, N., & Lund, S. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0277 · Cited by 380
Self-citationGlucagon physiology and pathophysiology in the light of new advances
Unger, R. H. (1985) · Diabetologia · doi:10.1007/bf00281991 · Cited by 361
Stain-Free total protein staining is a superior loading control to β-actin for Western blots
Gilda, J. E., & Gomes, A. V. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.05.027 · Cited by 331
The blood flow in skin and muscle of the human forearm
Cooper, K. E., Edholm, O. G., & Mottram, R. F. (1955) · The Journal of Physiology · doi:10.1113/jphysiol.1955.sp005304 · Cited by 298
Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients.
Nair, K. S., Ford, G. C., Ekberg, K., Fernqvist-Forbes, E., & Wahren, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118000 · Cited by 239
Recurrent Diabetic Ketoacidosis in Inner-City Minority Patients
Randall, L., Begovic, J., Hudson, M., Smiley, D., Peng, L., Pitre, N., Umpierrez, D., & Umpierrez, G. (2011) · Diabetes Care · doi:10.2337/dc11-0701 · Cited by 207
Rapid measurement of whole body and forearm protein turnover using a [2H5]phenylalanine model
Thompson, G. N., Pacy, P. J., Merritt, H., Ford, G. C., Read, M. A., Cheng, K. N., & Halliday, D. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.5.e631 · Cited by 202 · cited 1×
“Whole-body flux of phenylalanine (QPhe) and tyrosine (QTyr) was calculated as described previously [21], and is reported as synthesis, breakdown, and phenylalanine to tyrosine conversion.”
MethodChristiansen, J. J., Djurhuus, C. B., Gravholt, C. H., Iversen, P., Christiansen, J. S., Schmitz, O., Weeke, J., Jørgensen, J. O. L., & Møller, N. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0445 · Cited by 176
Self-citationMØLLER, N., JØRGENSEN, J. O. L., ALBERTI, K. G. M. M., FLYVBJERG, A., & SCHMITZ, O. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-1179 · Cited by 165
Self-citationCharacteristics of Diabetic Ketoacidosis in Older versus Younger Adults
Malone, M. L., Gennis, V., & Goodwin, J. S. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb01797.x · Cited by 152
Persisting Mortality in Diabetic Ketoacidosis
Basu, A., Close, C. F., Jenkins, D., Krentz, A. J., Nattrass, M., & Wright, A. D. (1993) · Diabetic Medicine · doi:10.1111/j.1464-5491.1993.tb00060.x · Cited by 145
Miles, J. M., Rizza, R. A., Haymond, M. W., & Gerich, J. E. (1980) · Diabetes · doi:10.2337/diab.29.11.926 · Cited by 142
Edgerton, D. S., Kraft, G., Smith, M., Farmer, B., Williams, P. E., Coate, K. C., Printz, R. L., O’Brien, R. M., & Cherrington, A. D. (2017) · JCI Insight · doi:10.1172/jci.insight.91863 · Cited by 126
Karakelides, H., Asmann, Y. W., Bigelow, M. L., Short, K. R., Dhatariya, K., Coenen-Schimke, J., Kahl, J., Mukhopadhyay, D., & Nair, K. S. (2007) · Diabetes · doi:10.2337/db07-0378 · Cited by 123
Miles, J. M., Haymond, M. W., Nissen, S. L., & Gerich, J. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110911 · Cited by 116
Effects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In Vivo
Edgerton, D. S., Ramnanan, C. J., Grueter, C. A., Johnson, K. M. S., Lautz, M., Neal, D. W., Williams, P. E., & Cherrington, A. D. (2009) · Diabetes · doi:10.2337/db09-0328 · Cited by 90
Direct Regulatory Effect of Ketones on Lipolysis and on Glucose Concentrations in Man
Senior, B., & Loridan, L. (1968) · Nature · doi:10.1038/219083a0 · Cited by 88
Nielsen, T. S., Vendelbo, M. H., Jessen, N., Pedersen, S. B., Jørgensen, J. O., Lund, S., & Møller, N. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0149 · Cited by 83
Self-citationSimilar Dose Responsiveness of Hepatic Glycogenolysis and Gluconeogenesis to Glucagon In Vivo
Stevenson, R. W., Steiner, K. E., Davis, M. A., Hendrick, G. K., Williams, P. E., Lacy, W. W., Brown, L., Donahue, P., Lacy, D. B., & Cherrington, A. D. (1987) · Diabetes · doi:10.2337/diab.36.3.382 · Cited by 83
Vendelbo, M. H., Clasen, B. F. F., Treebak, J. T., Møller, L., Krusenstjerna-Hafstrøm, T., Madsen, M., Nielsen, T. S., Stødkilde-Jørgensen, H., Pedersen, S. B., Jørgensen, J. O. L., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00207.2011 · Cited by 74
Self-citationSørensen, L. K., Rittig, N. F., Holmquist, E. F., Jørgensen, K. A., Jørgensen, J. O. L., Møller, N., & Johannsen, M. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2013.08.011 · Cited by 53
Self-citationNormal Physiology of ACTH and GH Release in the Hypothalamus and Anterior Pituitary in Man
Lim, C. T., & Khoo, B. C. E. (2025) · PubMed · Cited by 48
Rickels, M. R., Naji, A., & Teff, K. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2519 · Cited by 45
Leslie, P. J., Jung, R. T., Isles, T. E., Baty, J. D., Newton, R. W., & Illingworth, P. J. (1986) · BMJ · doi:10.1136/bmj.293.6555.1121 · Cited by 35
Arvat, E., Maccagno, B., Ramunni, J., Maccario, M., Giordano, R., Broglio, F., Camanni, F., & Ghigo, E. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430099 · Cited by 35
Møller, N., Jensen, M. D., Rizza, R. A., Andrews, J. C., & Nair, K. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0287-3 · Cited by 27
Self-citation�rskov, L., Bak, J. F., Abildg�rd, N., Schmitz, O., Andreasen, F., Richter, E. A., Skj�rb�k, C., & M⊘ller, N. (1996) · Diabetologia · doi:10.1007/bf00403967 · Cited by 22
Self-citationMøller, N., Jørgensen, J. O. L., Møller, J., Bak, J. F., Pørksen, N. K., Alberti, K. G. M. M., & Schmitz, O. (1990) · Metabolism · doi:10.1016/0026-0495(90)90189-j · Cited by 17
Self-citationSvart, M. V., Kampmann, U., Voss, T. S., Pedersen, S. B., Johannsen, M., Rittig, N. F., Poulsen, P. L., Nielsen, T. S., Jessen, N., & Møller, N. (2016) · Diabetes · doi:10.2337/db15-1645 · Cited by 17
Self-citationMortality of young patients with diabetes in Kinshasa, DR Congo
Muyer, M. T., Buntinx, F., Mapatano, M. A., Clerck, M. D., Truyers, C., & Muls, E. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02961.x · Cited by 16
Svart, M. V., Rittig, N. F., Kampmann, U., Voss, T. S., Møller, N., & Jessen, N. (2017) · Diabetologia · doi:10.1007/s00125-017-4271-x · Cited by 9
Self-citationBarbero (2014) · doi:10.1016/j · Cited by 1
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Ketone Body, 3-Hydroxybutyrate: Minor Metabolite - Major Medical Manifestations
Møller, N. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa370 · Cited by 158
Self-citationPerry, R. J., & Shulman, G. I. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.008387 · Cited by 147
Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus
Castellanos, L. E., Tuffaha, M., Koren, D., & Levitsky, L. L. (2020) · Pediatric Drugs · doi:10.1007/s40272-020-00397-0 · Cited by 139
Carpentier, A. C. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00620.2020 · Cited by 108
Metadata
- Authors
- Voss, T. S., Vendelbo, M. H., Kampmann, U., Pedersen, S. B., Nielsen, T. S., Johannsen, M., Svart, M. V., Jessen, N., & Møller, N.
- Affiliations
- Aarhus University (DK)
- Aarhus University Hospital (DK)
- University of Copenhagen (DK)
- Corresponding author
- Møller, Niels
- ORCID
- Venue
- Diabetologia
- Published
- 2018-12-01
- Volume
- 62
- Issue
- 3
- Pages
- 494-503
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2902564287
- Cited by
- 18
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 4
- FWCI
- 1.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Funders
- Aarhus Universitet
- The Danish Agency for Science Technology and Innovation (0603-00479)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, diabetic ketoacidosis, insulin withdrawal, insulin therapy, substrate metabolism, counterregulatory hormones, cytokines, Akt phosphorylation, G0S2, CGI-58, ABHD5, adipose triglyceride lipase, hormone-sensitive lipase, lipolysis, glucose turnover, muscle insulin resistance
- MeSH terms
- Adipose Tissue, Adult, Blood Glucose, Diabetes Mellitus, Type 1, Energy Metabolism, Humans, Hypoglycemic Agents, Insulin, Insulin Resistance, Ketosis, Lipolysis, Male, Middle Aged, Cytokines, Cross-Over Studies, Lipid Metabolism, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.